Odyssey Health, Inc. (ODYY) Form 8-K — May 11, 2026

$ODYYForm 8-KItems 1.01, 9.01Filed May 11, 2026, 5:10 PM ET0001683168-26-003682Original filing

On May 6, 2026, Odyssey Health, Inc. received a formal written notice from NeuRX Health, Inc. advising that NeuRX is in breach of its contractual obligations with Davion Healthcare Plc regarding the BreastCheck product. NeuRX failed to obtain Davion's required approval before sublicensing the product to Odyssey.

Price after filing

1 day: -40.2%7 days: -55.4%30 days: -87.1%

Close on the filing date to close N calendar days later (from $0.05). Historical, not a forecast.

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.